Re-appointment of Mr. Dhananjaya Alli (DIN: 00610909) as an Whole Time Director of company
Re-Appointment Of Mr. Dhananjaya Alli (DIN: 00610909) As An Whole Time Director Of The Company
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended 30.06.2025
- Results - Unaudited Financial Results For The Quarter Ended 30.06.2025
- Vista Pharmaceuticals Ltd. Press Release Aug 06 2025
- Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30.06.2025
- Vista Pharmaceuticals Ltd. Press Release Jul 16 2025
Later from Vista Pharmaceuticals
- Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An Whole Time Director Of The Company
- Re-Appointment Of Mr. Murali Meraga (DIN: 02537507) As An Managing Director Of The Company
- Vista Pharmaceuticals Ltd. Press Release Aug 13 2025
- 34Th Annual General Meeting Of Vista Pharmaceuticals Limited On Tuesday, 30Th September 2025
- Reg. 34 (1) Annual Report.
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals